A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of Healthy People
Status:
Not yet recruiting
Trial end date:
2022-04-11
Target enrollment:
Participant gender:
Summary
NN0365-3769 (Mim8) is a study medicine with the potential to prevent and reduce bleeding in
people with haemophilia A (an inherited disorder in which blood does not coagulate properly).
This study will investigate if different doses of Mim8 are safe, and also check how Mim8
behaves in the body.
Twelve different doses will be tested. Participants will only get one of the doses. Which
dose participants get is decided by chance. Participants will get a single injection under
the skin of the belly by means of a syringe and a needle.
The study will last for about 17 - 21 weeks.